News
30 March, 2023 - 15:30 (CEST)
Alerts
M
A 1st Invitation for Expression of Interest (EOI) for treatment of multi-drug resistant bacterial infections has been published by the WHO Prequalification Unit - Medicines Assessment Team (PQT/MED).
The below prodcut was added to the EOI:
Single ingredient medicine to treat multi-drug resistant bacterial infections
- Cefiderocol 1 g in vial (as sulfate toxylate) lyophilized powder for concentrate for solution for infusion.